A study of Gene expression and protein profiles to evaluate B and T cell immunity in multiple-sclerosis with anti-CD20 therapy
Latest Information Update: 16 Dec 2021
At a glance
- Drugs Interferon beta (Primary) ; Ocrelizumab (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 16 Dec 2021 New trial record